Study analysis · Alzheimer's & Dementia: Translational Research & Clinical Interventions · 2026
Creatine boosted energy in Alzheimer's patients—but only women saw their cells' power plants improve.
Giving Alzheimer's patients creatine made their blood cells produce more energy, but only women’s mitochondria got stronger.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This study watched what happened to 20 people after they took creatine for 8 weeks. It saw some changes in their blood, but we don’t know if creatine caused those changes — maybe they would’ve happened anyway. It’s like noticing your plant grew taller after you talked to it — you can’t say talking made it grow.
What’s the bottom line?
Scientists gave people with Alzheimer's a daily creatine pill for 8 weeks to see if it helps their cells make more energy.
How strong is this study?
This study didn’t have a comparison group or randomly assign people — it’s like giving everyone ice cream and saying it made them happier, without checking if they were already happy. That makes it hard to trust the results, because other things could’ve caused the changes.
40 / 100
- COI disclosure+40/40
- Data availabilitydata not shared
- Code availabilitycode not shared
15 / 100
- Randomizationnot randomized
- Blindingblinding unclear
- Control groupno control group
- Sample size (n=20)+1.9/20
- Follow-up+10/10
100 / 100
77 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervalsno confidence intervals
- Pre-registration+15/15
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 544 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
This design cannot establish causation — the findings describe an association, not a cause. This study lacks a control group, randomization, and blinding, making it impossible to rule out confounding factors or placebo effects. Changes observed could be due to time, natural variation, or other unmeasured influences.
Minor COI
Minor conflicts that may slightly influence the study
The study was funded by a company (Life Extension Inc.) that supplied the creatine monohydrate, but there is no explicit disclosure of author financial ties or funder involvement in study design or analysis.
Funders
Conflict Details
Life Extension Inc.: Supplied creatine monohydrate supplement used in the trial
No conflict of interest statement was provided. The funder supplied the supplement but did not appear to influence study design or analysis. However, the lack of a COI disclosure raises transparency concerns. The study's single-arm design and small sample size limit conclusions, but no evidence suggests data manipulation.
Key takeaways
- 01
In both men and women, blood cells had more ATP (+90%) and ADP (+63%).
- 02
Only women showed stronger mitochondrial energy production in blood cells.
- 03
Yes — more ATP/ADP means cells may have more usable energy, which could help brain and body function better, but it's not proven to improve memory or symptoms yet.
Surprising findings
- Creatine increased both ATP and ADP—but not the ATP/ADP ratio.Usually, more ATP means better energy efficiency. But here, ADP rose too, meaning cells were cycling energy faster—not necessarily more efficiently.
- Mitochondrial respiration improved in women but not men—even though both sexes got the same dose.Most supplements are assumed to work equally across sexes; this study flips that assumption, showing biology may respond differently based on sex hormones or genetics.
Practical takeaways
Consider taking 20g/day of creatine monohydrate for 8–12 weeks if you or a loved one has Alzheimer’s—especially if female—to potentially boost cellular energy.
This was a small, uncontrolled pilot—no proof it improves memory, mood, or daily function. Always consult a doctor before starting high-dose supplements.
low confidenceWhy this study matters
Energy Boost in Both Sexes
After 8 weeks of 20g/day creatine, lymphocyte ATP increased by 90% (p<0.001) and ADP by 63% (p<0.02) in both men and women with Alzheimer’s, suggesting improved cellular energy availability.
This means everyday cells—like those in the blood—may have more fuel to function, which could translate to better stamina, mood, or even brain function, even if brain scans didn’t show changes.
Female-Only Mitochondrial Surge
Only women showed significant increases in mitochondrial respiration across all key states (State 2, 3, 3S, Leak, Max)—with State 3 respiration jumping 2.66x in lymphocytes (Cohen’s dz = 2.66).
This could explain why some women with Alzheimer’s respond better to supplements—biology isn’t one-size-fits-all, and sex differences matter more than we thought.
Brain Scans Showed Nothing
Despite improved blood cell energy, brain NAA and GSH levels didn’t change at all (p=0.46 and p=0.12), meaning creatine didn’t visibly alter key brain biomarkers in 8 weeks.
It’s shocking that a supplement that boosted energy everywhere else didn’t touch the brain—suggesting the brain might need longer, or different, interventions.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists gave people with Alzheimer's a daily creatine pill for 8 weeks to see if it helps their cells make more energy.
Research results
In both men and women, blood cells had more ATP (+90%) and ADP (+63%). Only women showed stronger mitochondrial energy production in blood cells.
What this means - more context
Yes — more ATP/ADP means cells may have more usable energy, which could help brain and body function better, but it's not proven to improve memory or symptoms yet.
To assess whether 8 weeks of 20g/day creatine monohydrate supplementation improves bioenergetic biomarkers in Alzheimer's disease.
In 20 adults with Alzheimer's, creatine supplementation increased lymphocyte ATP and ADP in both sexes and mitochondrial respiration in females only; no changes were seen in brain NAA or GSH, or in lymphocyte ROS. The study lacked a control group.
Methods Used
Single-arm pilot with 20 Alzheimer's patients (35% female); 8 weeks of 20g/day creatine monohydrate. Biomarkers measured: brain NAA/GSH via 1H-MRS, mitochondrial respiration (platelets/lymphocytes) via Oroboros Oxygraph-2K, ATP/ADP via bioluminescent assay, ROS via flow cytometry.
Main Finding
Lymphocyte ATP increased significantly (p<0.001) and ADP increased (p<0.02) in both sexes; mitochondrial respiration increased in females across multiple states (p<0.05), but not in males. Brain NAA and GSH showed no change.
Confidence Level
Low — small sample (n=20), no control group, short duration (8 weeks), and single-arm design limit causal inference.
Study Flags
Red Flags
- •No control group
- •Small sample size (n=20)
- •Short duration (8 weeks)
Surprising Findings
Creatine increased both ATP and ADP—but not the ATP/ADP ratio.
Usually, more ATP means better energy efficiency. But here, ADP rose too, meaning cells were cycling energy faster—not necessarily more efficiently.
Practical Takeaways
Consider taking 20g/day of creatine monohydrate for 8–12 weeks if you or a loved one has Alzheimer’s—especially if female—to potentially boost cellular energy.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 544 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
Human Cross-Sectional
Subject
Moderate probability
on the GRADE evidence scale
This study watched what happened to 20 people after they took creatine for 8 weeks. It saw some changes in their blood, but we don’t know if creatine caused those changes — maybe they would’ve happened anyway. It’s like noticing your plant grew taller after you talked to it — you can’t say talking made it grow.
Minor conflicts detected — such as academic funding or advisory roles. These are common and have a small score impact.
Strengths
- Detailed and standardized biomarker measurements using validated techniques (MRS, Oroboros, flow cytometry)
- Use of pre- and post-intervention within-subject comparisons
- Clear reporting of statistical methods and effect sizes
Weaknesses
- No control group
- No randomization
- Blinding status unknown
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists gave people with Alzheimer's a daily creatine pill for 8 weeks to see if it helps their cells make more energy.
Research results
In both men and women, blood cells had more ATP (+90%) and ADP (+63%). Only women showed stronger mitochondrial energy production in blood cells.
What this means - more context
Yes — more ATP/ADP means cells may have more usable energy, which could help brain and body function better, but it's not proven to improve memory or symptoms yet.
To assess whether 8 weeks of 20g/day creatine monohydrate supplementation improves bioenergetic biomarkers in Alzheimer's disease.
In 20 adults with Alzheimer's, creatine supplementation increased lymphocyte ATP and ADP in both sexes and mitochondrial respiration in females only; no changes were seen in brain NAA or GSH, or in lymphocyte ROS. The study lacked a control group.
Methods Used
Single-arm pilot with 20 Alzheimer's patients (35% female); 8 weeks of 20g/day creatine monohydrate. Biomarkers measured: brain NAA/GSH via 1H-MRS, mitochondrial respiration (platelets/lymphocytes) via Oroboros Oxygraph-2K, ATP/ADP via bioluminescent assay, ROS via flow cytometry.
Main Finding
Lymphocyte ATP increased significantly (p<0.001) and ADP increased (p<0.02) in both sexes; mitochondrial respiration increased in females across multiple states (p<0.05), but not in males. Brain NAA and GSH showed no change.
Confidence Level
Low — small sample (n=20), no control group, short duration (8 weeks), and single-arm design limit causal inference.
Study Flags
Red Flags
- •No control group
- •Small sample size (n=20)
- •Short duration (8 weeks)
Surprising Findings
Creatine increased both ATP and ADP—but not the ATP/ADP ratio.
Usually, more ATP means better energy efficiency. But here, ADP rose too, meaning cells were cycling energy faster—not necessarily more efficiently.
Practical Takeaways
Consider taking 20g/day of creatine monohydrate for 8–12 weeks if you or a loved one has Alzheimer’s—especially if female—to potentially boost cellular energy.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 544 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
Human Cross-Sectional
Subject
Moderate probability
on the GRADE evidence scale
This study watched what happened to 20 people after they took creatine for 8 weeks. It saw some changes in their blood, but we don’t know if creatine caused those changes — maybe they would’ve happened anyway. It’s like noticing your plant grew taller after you talked to it — you can’t say talking made it grow.
Minor conflicts detected — such as academic funding or advisory roles. These are common and have a small score impact.
Strengths
- Detailed and standardized biomarker measurements using validated techniques (MRS, Oroboros, flow cytometry)
- Use of pre- and post-intervention within-subject comparisons
- Clear reporting of statistical methods and effect sizes
Weaknesses
- No control group
- No randomization
- Blinding status unknown
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
This study didn’t have a comparison group or randomly assign people — it’s like giving everyone ice cream and saying it made them happier, without checking if they were already happy. That makes it hard to trust the results, because other things could’ve caused the changes.
40 / 100
- COI disclosure+40/40
- Data availabilitydata not shared
- Code availabilitycode not shared
15 / 100
- Randomizationnot randomized
- Blindingblinding unclear
- Control groupno control group
- Sample size (n=20)+1.9/20
- Follow-up+10/10
100 / 100
77 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervalsno confidence intervals
- Pre-registration+15/15
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 544 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
This design cannot establish causation — the findings describe an association, not a cause. This study lacks a control group, randomization, and blinding, making it impossible to rule out confounding factors or placebo effects. Changes observed could be due to time, natural variation, or other unmeasured influences.
Minor COI
Minor conflicts that may slightly influence the study
The study was funded by a company (Life Extension Inc.) that supplied the creatine monohydrate, but there is no explicit disclosure of author financial ties or funder involvement in study design or analysis.
Funders
Conflict Details
Life Extension Inc.: Supplied creatine monohydrate supplement used in the trial
No conflict of interest statement was provided. The funder supplied the supplement but did not appear to influence study design or analysis. However, the lack of a COI disclosure raises transparency concerns. The study's single-arm design and small sample size limit conclusions, but no evidence suggests data manipulation.